1 active not recruiting, 1 completed, 1 recruiting. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Galaxy Therapeutics INC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial The SEAL™ Saccular Endovascular Aneurysm Lattice System - Intracranial Aneurysm | Phase 3 | Active not recruiting | Galaxy Therapeutics INC | 279 | 2024-08-06 | 2026-01-16 |
| SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry SEAL Device - Aneurysm, Aneurysm, Ruptured | Recruiting | Galaxy Therapeutics INC | 200 | 2023-10-09 | 2025-04-04 | |
| Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial SEAL Device - Aneurysms Saccular, Aneurysm, Ruptured | Not applicable | Completed | Galaxy Therapeutics INC | 26 | 2022-01-26 | 2024-04-04 |
Aneurysm (2) · Aneurysm, Ruptured (2) · Intracranial Aneurysm (1)
Colombia (2) · New Zealand (1) · Pakistan (1) · Spain (1) · United States (1)
Brian Jankowitz, MD (1) · David Altschul, MD (1) · Osama Zaidat, MD, MS (1)